104 related articles for article (PubMed ID: 1377928)
21. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
22. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Moore MA; Warren DJ
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
[TBL] [Abstract][Full Text] [Related]
23. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group.
Aso Y; Akaza H
J Urol; 1992 Apr; 147(4):1060-4. PubMed ID: 1372661
[TBL] [Abstract][Full Text] [Related]
24. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
[TBL] [Abstract][Full Text] [Related]
25. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
Hamood M; Bluche PF; De Vroey C; Corazza F; Bujan W; Fondu P
Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human granulocyte colony-stimulating factor inhibits the metastasis of hematogenous and non-hematogenous tumors in mice.
Matsumoto Y; Saiki I; Murata J; Okuyama H; Tamura M; Azuma I
Int J Cancer; 1991 Sep; 49(3):444-9. PubMed ID: 1717386
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic activity (leukopoietic effect) of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after rectal administration in rabbits with leukopenia induced by cyclophosphamide.
Watanabe Y; Kiriyama M; Oe J; Kikuchi R; Mizufune Y; Matsumoto M
Biol Pharm Bull; 1996 Aug; 19(8):1064-7. PubMed ID: 8874817
[TBL] [Abstract][Full Text] [Related]
28. [Granulocyte colony stimulating factor (G-CSF) in treatment of patients with HIV-associated mucocutaneous Kaposi sarcoma. Successful use in virus and drug-induced leukopenia].
Schröder K; Garbe C; Waibel M; Reupke H; Detmar M; Dallenbach F; Orfanos CE
Hautarzt; 1992 Nov; 43(11):700-6. PubMed ID: 1281810
[TBL] [Abstract][Full Text] [Related]
29. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
[TBL] [Abstract][Full Text] [Related]
31. Effect of interleukin-4 on the growth of granulocyte-macrophage progenitor cells stimulated by hematopoietic growth factors.
Sato T; Misago M; Tsukada J; Kikuchi M; Oda S; Chiba S; Eto S
J UOEH; 1990 Jun; 12(2):163-74. PubMed ID: 1697091
[TBL] [Abstract][Full Text] [Related]
32. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
Yoshida M
Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
[TBL] [Abstract][Full Text] [Related]
33. Influence of the joint treatment with granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on erythropoietic recovery following 5-fluorouracil-induced haematotoxicity in mice.
Weiterová L; Hofer M; Pospísil M; Znojil V; Vácha J; Vacek A; Pipalová I
Eur J Haematol; 2000 Nov; 65(5):310-6. PubMed ID: 11092461
[TBL] [Abstract][Full Text] [Related]
34. An increase in peripheral blood progenitor cells in primates by coadministration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
Suzuki H; Ikebuchi K; Wada Y; Okano A; Nakamiya T; Akiyama Y; Sawada T; Asano S; Nakahata T
Transplantation; 1997 Nov; 64(10):1468-73. PubMed ID: 9392313
[TBL] [Abstract][Full Text] [Related]
35. Enhanced effect of mutant granulocyte-colony-stimulating factor (KW-2228) on the growth of normal and leukemic hemopoietic progenitor cells in comparison with recombinant human granulocyte-colony-stimulating factor (G-CSF).
Suzuki T; Tohda S; Nagata K; Imai Y; Murohashi I; Nara N
Acta Haematol; 1992; 87(4):181-9. PubMed ID: 1381543
[TBL] [Abstract][Full Text] [Related]
36. [Use of G-CSF (Neupogen) in multimodal treatment in radiotherapy].
Bartzsch O; Riepl M; Busch M; Michael G; Allgäuer M; Voss AC; Sauer R; Dühmke E; Gademann G; Molls M
Strahlenther Onkol; 1998 Nov; 174(11):551-5. PubMed ID: 9830435
[TBL] [Abstract][Full Text] [Related]
37. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on cytotoxicity of PSK-induced peritoneal polymorphonuclear leukocytes (PMNs).
Kato H; Inoue M; Yamamura Y; Kawahito Y; Mukai S; Sugino S; Kondo M
Biotherapy; 1992; 5(3):177-86. PubMed ID: 1384634
[TBL] [Abstract][Full Text] [Related]
38. Effects of granulocyte-colony stimulating factor on peritoneal defense mechanisms and bacterial translocation after administration of systemic chemotherapy in rats.
Cerci C; Ergin C; Eroglu E; Agalar C; Agalar F; Cerci S; Bulbul M
World J Gastroenterol; 2007 May; 13(18):2596-9. PubMed ID: 17552008
[TBL] [Abstract][Full Text] [Related]
39. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
40. Measurements of plasma elastase alpha 1-proteinase inhibitor complexes in patients receiving cancer chemotherapy with granulocyte colony-stimulating factor.
Fujita J; Xu G; Miyawaki H; Yamaji Y; Takahara J
Chest; 1995 May; 107(5):1350-4. PubMed ID: 7538456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
